Immutep (IMMP) vs NextCure (NXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immutep (IMMP) has outperformed NextCure (NXTC) over the past year, gaining 95.2% versus a gain of 7.1%. Over five years, IMMP leads with a +2.8% price change compared with -93.7% for NXTC. NextCure is the larger company by market cap ($30.0 million vs $29.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMMP | NXTC |
|---|---|---|
| Share price | $4.06 | $6.56 |
| Market cap | $29.92M | $30.03M |
| 1-day change | -6.45% | +15.39% |
| YTD return | +41.96% | -53.77% |
| 1-year return | +95.19% | +7.07% |
| 5-year return | +2.78% | -93.74% |
| EPS (TTM) | $-6.82 | $-10.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $70.60 | $15.74 |
| 52-week low | $4.04 | $1.55 |
| Distance from 52-week high | -94.25% | -58.32% |
| Average volume | 14.78K | 2.11M |
| Shares outstanding | 7.37M | 4.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMP has outperformed NXTC by 88.1 percentage points over the past year.
IMMP vs NXTC FAQ
Which is bigger, Immutep or NextCure?
NextCure (NXTC) is larger, with a market capitalization of $30.03M compared with $29.92M for Immutep (IMMP).
Which stock has performed better over the past year, IMMP or NXTC?
IMMP returned +95.19% over the past 12 months, compared with +7.07% for NXTC (price return, excluding dividends). Past performance does not predict future results.
Are Immutep and NextCure in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.